Related Experiment Videos
Maternal malaria: Plasmodium falciparum sequestration in the placenta
Katherine T Andrews1, Michael Lanzer
1Hygiene-Institut, Abteilung Parasitologie, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.
Parasitology Research
|July 18, 2002
Summary
First-time pregnant women face severe malaria risks from Plasmodium falciparum due to placental sequestration. Subsequent pregnancies offer protection via antibodies preventing infected red blood cell adhesion.
Area of Science:
- Immunology
- Infectious Diseases
- Obstetrics
Background:
- Plasmodium falciparum causes millions of malaria cases and deaths annually.
- Pregnant women, especially during their first pregnancy, are highly susceptible to severe malaria.
- Placental malaria complications include premature delivery, intrauterine growth retardation, and maternal/newborn death.
Purpose of the Study:
- To summarize current knowledge on the pathophysiology of maternal malaria.
- To discuss emerging intervention strategies for placental malaria.
Main Methods:
- Review of existing literature on Plasmodium falciparum pathophysiology in pregnancy.
- Analysis of immune mechanisms protecting against placental malaria in subsequent pregnancies.
Main Results:
- Plasmodium falciparum infected erythrocytes adhere to the placenta, causing pathology.
- Immunity developed in subsequent pregnancies prevents this cytoadhesion.
- Understanding these mechanisms is key for developing interventions.
Conclusions:
- Maternal malaria poses significant risks, particularly in first pregnancies.
- Immunity to placental cytoadhesion develops over time.
- Targeting parasite sequestration and host immunity offers potential intervention pathways.